Addario Institute, Biocept collaborate on liquid biopsy trial in lung cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Addario Lung Cancer Medical Institute and Biocept Inc. announced a clinical collaboration and initiation of the landmark ALCMI-009 liquid biopsy clinical trial, which was developed and will be conducted by ALCMI and its consortium of leading U.S. and international oncology centers.

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login